
CGEM
Healthcare · Biotechnology · $667.4M market cap
$10.27+0.08 (+0.8%)Nov 13, 4:00 PM EST
Latest report
Before the open
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Dec 31, 2026
EPS trend, 90 days to now · -40.4% over 90 days · 30-day revisions 3 up, 0 down
Beat estimates in 3 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Nov 10, 2026 | Before the open | -0.79 | -0.74 | +6.3% |
| Aug 6, 2026 | Before the open | -0.71 | -0.81 | -14.1% |
| May 7, 2026 | Before the open | -0.84 | -0.75 | +10.7% |
| Mar 5, 2026 | Time not confirmed | -0.87 | -0.77 | +11.9% |
| Nov 6, 2025 | Before the open | -0.89 | -0.77 | +13.5% |
| Aug 7, 2025 | Before the open | -0.83 | -1.07 | -28.9% |
| May 8, 2025 | Before the open | -0.81 | -0.74 | +8.6% |
| Mar 12, 2025 | Before the open | -0.74 | -0.73 | +1.7% |
| Nov 7, 2024 | Before the open | -0.77 | -0.69 | +10.4% |
| Aug 8, 2024 | Before the open | -0.73 | -0.75 | -2.7% |
| May 15, 2024 | After the close | -0.99 | -0.86 | +13.1% |
| Mar 14, 2024 | Before the open | -0.98 | -0.54 | +44.9% |
| Nov 8, 2023 | Before the open | -0.94 | -0.91 |
Cullinan Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops therapies for autoimmune diseases and cancer in the United States. It engages in the development of CLN-978, a CD19xCD3 bispecific T cell engager for autoimmune diseases in Phase 1 clinical trials; Velinotamig, a BCMAxCD3 bispecific T cell in Phase 1 clinical trials in patients with autoimmune diseases; and CLN-049, a FLT3xCD3…
| +3.2% |
| Aug 10, 2023 | Before the open | -1.00 | -0.82 | +18.0% |
| May 11, 2023 | After the close | -0.98 | -1.42 | -44.9% |
| Mar 9, 2023 | Before the open | -0.71 | -0.59 | +16.9% |
| Nov 14, 2022 | Before the open | -0.97 | -0.54 | +44.3% |
| Aug 10, 2022 | Before the open | 5.42 | 3.77 | -30.4% |
| May 16, 2022 | Before the open | -0.55 | -0.27 | +50.9% |
| Mar 17, 2022 | Before the open | -0.47 | -0.74 | -57.4% |
| Nov 9, 2021 | Before the open | -0.43 | -0.50 | -16.3% |
| Aug 10, 2021 | Before the open | -0.42 | -0.36 | +14.3% |
| May 14, 2021 | Before the open | 0.03 | -0.00 | -105.7% |
| Mar 30, 2021 | Before the open | -0.38 | -2.86 | -652.6% |
| Nov 2, 2020 | Time not confirmed | — | -0.24 | — |
| Sep 30, 2020 | Time not confirmed | 0.00 | -1.02 | — |
| Jun 30, 2020 | Time not confirmed | 0.00 | -0.79 | — |
| Mar 31, 2020 | Time not confirmed | 0.00 | -0.79 | — |
| Sep 30, 2019 | Time not confirmed | 0.00 | -0.97 | — |
| Jun 30, 2019 | Time not confirmed | 0.00 | -0.84 | — |
| Mar 31, 2019 | Time not confirmed | 0.00 | -0.84 | — |